TY - JOUR
T1 - Improving clinician performance of inpatient venous thromboembolism risk assessment and prophylaxis.
AU - Goldhaber, Samuel Z.
AU - Ortel, Thomas L.
AU - Berry, Carolyn A.
AU - Stowell, Stephanie A.
AU - Gardner, Allison J.
N1 - Funding Information:
The authors thank Martha Inglis-LeGall and Whitney Stevens for project management; Catherine Mullaney and LaWanda Abernathy for participant recruitment; Kenny Khoo for data management; Amy Sison and Kristin Hartman for outcomes management; Samantha Roberts for CME coordination; Kieran Hartsough and Kelly Quinn for assistance with data analysis; Lisa Rinehart for editorial assistance, and Sara Metzger for assistance with graphic design. This initiative was supported by an unrestricted educational grant from Ortho-McNeil™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC and sanofi-aventis U.S. Inc., a sanofi company. The funding sources had no role in the execution, analysis, or development of the resulting manuscript associated with the initiative.
Copyright:
Copyright 2017 Medline is the source for the citation and abstract of this record.
PY - 2013/4
Y1 - 2013/4
N2 - Clinicians are aware of the importance of thromboprophylaxis, and that the application of measures to prevent venous thromboembolism (VTE) occurrence in hospitalized patients must be improved. To enhance clinician execution of appropriate steps to reduce the risk of inpatient VTE, a performance improvement (PI) continuing medical education (CME) initiative consisting of 3 independent tracks for hospitalized patients-patients who are medically ill, patients receiving oncology treatment, and patients undergoing major orthopedic surgery-was designed and implemented. After a baseline chart review of select evidenced-based performance measures for VTE risk stratification and prevention, participants identified ≥ 1 area of personal improvement. Participants then engaged in a period of self-improvement and reassessed their performance with a second chart review. After participating in the PI CME activity, clinician participants in the medically ill track increased their documentation of VTE risk assessments upon patient admission from baseline (56% vs 93%, n = 250; P < 0.001) and their prescription of low-molecular-weight heparin, low-dose unfractionated heparin, or fondaparinux (72% vs 88%, n = 250; P < 0.001). Orthopedic-track participants were significantly more likely to prescribe 15 to 35 days of VTE prophylaxis after total hip arthroplasty or hip fracture surgery upon patient discharge compared with baseline (51%, n = 123 vs 61%, n = 107; P < 0.001). Oncology-track participants demonstrated a nonsignificant trend for assessing and documenting bleeding risk after participation in the PI CME activity (56% vs 68%, n = 80; P = 0.143). Improvements in evidence-based strategies to reduce the risk of inpatient VTE were associated with PI CME participation. Although areas for improvement remain, increased participant identification and use of prophylactic measures can reduce the risk of VTE in hospitalized patients.
AB - Clinicians are aware of the importance of thromboprophylaxis, and that the application of measures to prevent venous thromboembolism (VTE) occurrence in hospitalized patients must be improved. To enhance clinician execution of appropriate steps to reduce the risk of inpatient VTE, a performance improvement (PI) continuing medical education (CME) initiative consisting of 3 independent tracks for hospitalized patients-patients who are medically ill, patients receiving oncology treatment, and patients undergoing major orthopedic surgery-was designed and implemented. After a baseline chart review of select evidenced-based performance measures for VTE risk stratification and prevention, participants identified ≥ 1 area of personal improvement. Participants then engaged in a period of self-improvement and reassessed their performance with a second chart review. After participating in the PI CME activity, clinician participants in the medically ill track increased their documentation of VTE risk assessments upon patient admission from baseline (56% vs 93%, n = 250; P < 0.001) and their prescription of low-molecular-weight heparin, low-dose unfractionated heparin, or fondaparinux (72% vs 88%, n = 250; P < 0.001). Orthopedic-track participants were significantly more likely to prescribe 15 to 35 days of VTE prophylaxis after total hip arthroplasty or hip fracture surgery upon patient discharge compared with baseline (51%, n = 123 vs 61%, n = 107; P < 0.001). Oncology-track participants demonstrated a nonsignificant trend for assessing and documenting bleeding risk after participation in the PI CME activity (56% vs 68%, n = 80; P = 0.143). Improvements in evidence-based strategies to reduce the risk of inpatient VTE were associated with PI CME participation. Although areas for improvement remain, increased participant identification and use of prophylactic measures can reduce the risk of VTE in hospitalized patients.
UR - http://www.scopus.com/inward/record.url?scp=84880541526&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880541526&partnerID=8YFLogxK
U2 - 10.3810/hp.2013.04.1061
DO - 10.3810/hp.2013.04.1061
M3 - Article
C2 - 23680743
AN - SCOPUS:84880541526
SN - 0304-3975
VL - 41
SP - 123
EP - 131
JO - Unknown Journal
JF - Unknown Journal
IS - 2
ER -